| Literature DB >> 28772664 |
Wei-Qing Kong1, Cun-Dian Gao2, Shu-Feng Hu3, Jun-Li Ren4, Li-Hong Zhao5, Run-Cang Sun6.
Abstract
Among the natural macromolecules potentially used as the scaffold material in hydrogels, xylan has aroused great interest in many fields because of its biocompatibility, low toxicity, and biodegradability. In this work, new pH and thermoresponsive hydrogels were prepared by the cross-linking polymerization of maleic anhydride-modified xylan (MAHX) with N-isopropylacrylamide (NIPAm) and acrylic acid (AA) under UV irradiation to form MAHX-g-P(NIPAm-co-AA) hydrogels. The pore volume, the mechanical properties, and the release rate for drugs of hydrogels could be controlled by the degree of substitution of MAHX. These hydrogels were characterized by swelling ability, lower critical solution temperature (LCST), Fourier-transform infrared (FTIR), and SEM. Furthermore, the cumulative release rate was investigated for acetylsalicylic acid and theophylline, as well as the cytocompatibility MAHX-based hydrogels. Results showed that MAHX-based hydrogels exhibited excellent swelling-deswelling properties, uniform porous structure, and the temperature/pH dual sensitivity. In vitro, the cumulative release rate of acetylsalicylic acid for MAHX-based hydrogels was higher than that for theophylline, and in the gastrointestinal sustained drug release study, the acetylsalicylic acid release rate was extremely slow during the initial 3 h in the gastric fluid (24.26%), and then the cumulative release rate reached to 90.5% after sustained release for 5 h in simulated intestinal fluid. The cytotoxicity experiment demonstrated that MAHX-based hydrogels could promote cell proliferation and had satisfactory biocompatibility with NIH3T3 cells. These results indicated that MAHX-based hydrogels, as new drug carriers, had favorable behavior for intestinal-targeted drug delivery.Entities:
Keywords: Keywords: modified xylan; biocompatibility; drug controlled release; hydrogels; temperature/pH dual sensitivity
Year: 2017 PMID: 28772664 PMCID: PMC5503382 DOI: 10.3390/ma10030304
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Degree of substitution (DS) of maleic anhydride-modified xylan (MAHX) and the preparation conditions of MAHX-based hydrogels.
| Samples | MAH/xylan | DS of MAHX | NIPAm/MAHX (g/g) | AA/MAHX (g/g) | MBA/MAHX (g/g) |
|---|---|---|---|---|---|
| gel-1 | 1:1 | 0.12 | 0.1 | 10:1 | 0.1 |
| gel-2 | 2:1 | 0.28 | 0.1 | 10:1 | 0.1 |
| gel-3 | 4:1 | 0.48 | 0.1 | 10:1 | 0.1 |
| gel-4 | 8:1 | 0.65 | 0.1 | 10:1 | 0.1 |
AA: acrylic acid; MBA: N,N’-methylene-bis-acrylamide; NIPAm: N-isopropylacrylamide.
Figure 1The influences of the temperature (25–37 °C) and pH (7.4 (a) and 1.5 (b)) on the swelling ratio (Seq) of MAHX-gels.
Figure 2Reversible swelling–deswelling behavior of gel-3 in the buffer solutions with pH 1.5 and 7.4 at 37 °C.
Figure 3SEM images of xylan (a); MAHX (b); and freeze-dried gel-1 (c); gel-2 (d); gel-3 (e); and gel-4 (f). The hydrogel samples swelled at 37 °C and freeze-dried before determination.
The compressive properties and drug-loading and encapsulation efficiency of hydrogels.
| Samples | Compression Stress (kPa) | Elasticity Modulus (kPa) | Drug a Loading (%) | Encapsulation Efficiency (%) | LCST (°C) |
|---|---|---|---|---|---|
| gel-1 | 56.34 ± 3.68 | 78.54 ± 9.48 | 55.26 | 86.56 | 33.4 |
| gel-2 | 60.42 ± 4.23 | 128.25 ± 6.56 | 58.2 | 89.62 | 33.7 |
| gel-3 | 68.25 ± 3.34 | 168.67 ± 8.54 | 60.68 | 92.25 | 34.3 |
| gel-4 | 67.56 ± 2.68 | 164.34 ± 8.78 | 58.45 | 90.56 | 34.2 |
LCST: lower critical solution temperature; a acetylsalicylic acid drug loading.
Figure 4Fourier-transform infrared (FTIR) spectra of xylan, MAHX, and gel-3.
Figure 5Differential scanning calorimetry (DSC) curves of hydrogels.
Figure 6In vitro cumulative drug release from the drug-loaded gel-3 in simulated gastric and intestinal fluids at 37 °C: (a) acetylsalicylic acid and (b) theophylline.
Figure 7Acetylsalicylic acid release performance of gel-3 in pH 1.5 buffer solution for 3 h followed by the drug’s release in pH 7.4 for 10 h at 37 °C.
Figure 8NIH3T3 cell viability of gel-3 under the different concentrations of 1.6–0.05 mg/mL after cultivating for 24 h and 72 h.
Figure 9The micrographs of NIH3T3 cell distribution under the different concentrations of gel-3 samples: (a) cultivation for 24 h; (b) cultivation for 72 h.